Corpus 1,276 assessed · 1,177 scored · 644 reproduced ≥75 · 170 flagged ·∅ 74/100

Publications 2 Datasets 392.5k Experiments 4.7k

Explore

Filters: 1 ✕ 1 ✕ mass cytometry (cytof) ✕ clear all

2 matching publication(s)

Publication	Journal	Year	Score	Verdict
RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia. PMID 39820365	Nat Commun	2025	73	L1 73/100
Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic l PMID 37217248	J Immunother Cancer	2023	76	L1 76/100

RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia.

PMID 39820365 · Nat Commun · 2025

L1 73/100

Intrinsic suppression of type I interferon production underlies the therapeutic efficacy of IL-15-producing natural killer cells in B-cell acute lymphoblastic l

PMID 37217248 · J Immunother Cancer · 2023

L1 76/100